GSK India - Vaccines, Specialty and General Medicines
Our portfolio spans three product areas: vaccines, specialty and general medicines. Globally, we’re prioritising R&D investment in vaccines and specialty medicines, which we expect to grow to around three quarters of our business by 2026.
Click to Visit Site